This Experimental Drug Could Be a Game Changer for Pancreatic Cancer by Ed Cara from Gizmodo on 2026-04-14 16:45 (#74YAZ) In a Phase III trial, Revolution Medicines' daraxonrasib almost doubled the survival length of people with advanced pancreatic cancer.
